Medicinal Δ 9-tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests

Addiction

Volumn 107, Issue 10, 2012, Pages 1837-1844

  Bosker, Wendy M ^a   Kuypers, Kim P C ^a   Theunissen, Eef L ^a   Surinx, Anke ^a   Blankespoor, Roos J ^a   Skopp, Gisela ^b   Jeffery, Wayne K ^c   Walls, H Chip ^d   van Leeuwen, Cees J ^a   Ramaekers, Johannes G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c Forensic Alcohol and Drug Recognition Expert   (Canada)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

9 tetrahydrocannabinol; Cannabis; Driving; Dronabinol; DUID; SFST; THC

Indexed keywords

PSYCHOTROPIC AGENT; TETRAHYDROCANNABINOL;

ADULT; ARTICLE; CANNABIS ADDICTION; CAR DRIVING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; SUBSTANCE ABUSE;

ADMINISTRATION, ORAL; AUTOMOBILE DRIVING; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; PSYCHOMOTOR PERFORMANCE; PSYCHOTROPIC DRUGS; SUBSTANCE ABUSE DETECTION; TETRAHYDROCANNABINOL; YOUNG ADULT;

EID: 84866045303     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2012.03928.x     Document Type: Article

References (26)

1. Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2008 National Survey on Drug Use and Health: National Findings. NSDUH Series H-36, HHS Publication no. SMA 09-4434. Rockville, MD: Office of Applied Studies; 2009.
2. Lacey J. H., Kelley-Baker T., Furr-Holden D., Voas E. B., Romano E., Ramirez A. etal. 2007 National Roadside Survey of Alcohol and Drug Use by Drivers: Drug Results (DOT HS 811 249). Washington: US Department of Transportation, National Highway Traffic Safety Administration. 2009.
3. National Highway Traffic Safety Administration (NHTSA). FARS data query. 2009. Available at http://www-fars.nhtsa.dot.gov/Main/index.aspx (accessed 17 June 2012).
4. Grotenhermen F., Leson G., Berghaus G., Drummer O. H., Krueger H. P., Longo M. etal. Developing limits for driving under cannabis. Addiction 2007; 102: 1910-1917.
5. Ramaekers J. G., Berghaus G., van Laar M., Drummer O. H. Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend 2004; 73: 109-119.
6. Ramaekers J. G., Robbe H. W., O'Hanlon J. F. Marijuana, alcohol and actual driving performance. Hum Psychopharmacol 2000; 15: 551-558.
7. McGilveray I. J. Pharmacokinetics of cannabinoids. Pain Res Manag 2005; 10: 15A-22A.
8. Ramaekers J. G., Moeller M. R., van Ruitenbeek P., Theunissen E. L., Schneider E., Kauert G. Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment. Drug Alcohol Depend 2006; 85: 114-122.
9. Ramaekers J. G., Kauert G., Theunissen E. L., Toennes S. W., Moeller M. R. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. J Psychopharmacol 2009; 23: 266-277.
10. Gray K. M., Hart C. L., Christie D. K., Upadhyaya H. P. Tolerability and effects of oral Delta9-tetrahydrocannabinol in older adolescents with marijuana use disorders. Pharmacol Biochem Behav 2008; 91: 67-70.
11. Curran H. V., Brignell C., Fletcher S., Middleton P., Henry J. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology (Berl) 2002; 164: 61-70.
12. Kirk J. M., de Wit H. Responses to oral delta9-tetrahydrocannabinol in frequent and infrequent marijuana users. Pharmacol Biochem Behav 1999; 63: 137-142.
13. Menetrey A., Augsburger M., Favrat B., Pin M. A., Rothuizen L. E., Appenzeller M. etal. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20mg dronabinol or of a cannabis decoction made with 20 or 60mg Delta9-THC. J Anal Toxicol 2005; 29: 327-338.
14. Robbe H. Marijuana's impairing effects on driving are moderate when taken alone but severe when combined with alcohol. Hum Psychopharmacol Clin Exp 1998; 13: S70-78.
15. Ramaekers J. G., Theunissen E. L., de Brouwer M., Toennes S. W., Moeller M. R., Kauert G. Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis. Psychopharmacology 2011; 214: 391-401.
16. Hart C. L., van Gorp W., Haney M., Foltin R. W., Fischman M. W. Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology 2001; 25: 757-765.
17. O'Hanlon J. F. Driving performance under the influence of drugs: rationale for, and application of, a new test. Br J Clin Pharmacol 1984; 18: 121S-129.
18. Louwerens J., Gloerich A., de Vries G., Brookhuis K., O'Hanlon J. The relationship between drivers' blood alcohol concentration (BAC) and actual driving performance during high speed travel. Alcohol Drugs Traffic Saf 1987; 86: 183-186.
19. O'Hanlon J. F., Haak T. W., Blaauw G. J., Riemersma J. B. Diazepam impairs lateral position control in highway driving. Science 1982; 217: 79-81.
20. Ramaekers J. G. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. J Clin Psychiatry 2003; 64: 20-29.
21. Brookhuis K. A., de Waard D., Mulder B. Measuring driving performance by car-following in traffic. Ergonomics 1994; 37: 427-434.
22. Ramaekers J. G., Lamers J., Verhey F., Muntjewerff D., Mobbs E., Sanders N. etal. A comparative study of the effects of carbamazepine and the NMDA receptor antagonist remacemide on road tracking and car-following performance in actual traffic. Psychopharmacology (Berl) 2002; 159: 203-210.
23. Stuster J., Burns M. Validation of the Standardized Field Sobriety Test Battery at BACs Below 0.10. DOT-HS-808-839. Washington, DC: US Department of Transportation, National Highway Traffic Safety Administration; 1998.
24. Papafotiou K., Carter J. D., Stough C. An evaluation of the sensitivity of the Standardised Field Sobriety Tests (SFSTs) to detect impairment due to marijuana intoxication. Psychopharmacology (Berl) 2005; 180: 107-114.
25. Hart C. L., Ward A. S., Haney M., Comer S. D., Foltin R. W., Fischman M. W. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans. Psychopharmacology (Berl) 2002; 164: 407-415.
26. Papafotiou K., Carter J. D., Stough C. The relationship between performance on the standardised field sobriety tests, driving performance and the level of Delta9-tetrahydrocannabinol (THC) in blood. Forensic Sci Int 2005; 155: 172-178.